These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 22793971
1. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy. Duman EN, Saylan S, Cekic B. Rev Bras Anestesiol; 2012 Jul; 62(4):548-53. PubMed ID: 22793971 [Abstract] [Full Text] [Related]
2. New Insights Into the Treatment of Glanzmann Thrombasthenia. Poon MC, Di Minno G, d'Oiron R, Zotz R. Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829 [Abstract] [Full Text] [Related]
3. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia. Franchini M, Lippi G. Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838 [Abstract] [Full Text] [Related]
4. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa. Javed A, Ayyub M, Abrar S, Mansoor M, Khan B, Hussain T. J Ayub Med Coll Abbottabad; 2009 Dec; 21(2):171-3. PubMed ID: 20524499 [Abstract] [Full Text] [Related]
6. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry. Recht M, Rajpurkar M, Chitlur M, d'Oiron R, Zotz R, Di Minno G, Cooper DL, Poon MC. Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369 [Abstract] [Full Text] [Related]
7. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature. Rajpurkar M, Chitlur M, Recht M, Cooper DL. Haemophilia; 2014 Jul; 20(4):464-71. PubMed ID: 24948404 [Abstract] [Full Text] [Related]
8. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia. Poon MC. Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022 [Abstract] [Full Text] [Related]
9. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. Poon MC, D'Oiron R, Von Depka M, Khair K, Négrier C, Karafoulidou A, Huth-Kuehne A, Morfini M, International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group. J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192 [Abstract] [Full Text] [Related]
10. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents. Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y. Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383 [Abstract] [Full Text] [Related]